GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 18, 2024 |
PDB ID | UniProt ID ▼ | Title | Descriptor |
---|---|---|---|
6CNJ | 6CNJ | Structure of the 2alpha3beta stiochiometry of the human Alpha4Beta2 nicotinic receptor | Neuronal acetylcholine receptor subunit alpha-4,Neuronal acetylcholine receptor subunit beta-2,IgG1 Kappa Light Chain, IgG1 Heavy Chain |
6CMX | 6CMX | Human Teneurin 2 extra-cellular region | |
6CMO | 6CMO | Rhodopsin-Gi complex | |
6CMI | 6CMI | Crystal Structure of the Hendra Virus Attachment G Glycoprotein Bound to a Potent Cross-Reactive Neutralizing Human Monoclonal Antibody m102.3 | |
6CMG | 6CMG | Crystal Structure of the Hendra Virus Attachment G Glycoprotein Bound to a Potent Cross-Reactive Neutralizing Human Monoclonal Antibody m102.3 | |
6CM3 | 6CM3 | BG505 SOSIP in complex with sCD4, 17b, 8ANC195 | Envelope glycoprotein gp160, T-cell surface glycoprotein CD4, 17b Fab light chain, 17b Fab heavy chain, 8ANC195 Fab heavy chain, 8ANC195 Fab light chain |
6CK9 | 6CK9 | Crystal Structure of HIV-1 ConC_Base0 Prefusion Env Trimer in Complex with Human Antibody Fragment 3H109L and 35O22 variants at 3.5 Angstrom | |
6CJ9 | 6CJ9 | Crystal structure of lectin from Dioclea lasiophylla seeds (DlyL) complexed with X-Man | |
6CH9 | 6CH9 | Crystal structure of a natively-glycosylated B41 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22 | |
6CH8 | 6CH8 | Crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22 | |
6CH7 | 6CH7 | XFEL crystal structure of a natively-glycosylated BG505 SOSIP.664 HIV-1 Envelope Trimer in complex with the broadly-neutralizing antibodies BG18 and 35O22 | Envelope glycoprotein gp160, 35O22 Heavy Chain, 35O22 Light Chain, BG18 Heavy Chain, BG18 Light Chain |
6CE0 | 6CE0 | Crystal structure of a HIV-1 clade B tier-3 isolate H078.14 UFO-BG Env trimer in complex with broadly neutralizing Fabs PGT124 and 35O22 at 4.6 Angstrom | |
6CDI | 6CDI | Cryo-EM structure at 3.6 A resolution of vaccine-elicited antibody vFP16.02 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | VRC03 Heavy Chain, VRC03 light chain, PGT122 Heavy Chain, PGT122 Light Chain, Glycoprotein 120, Glycoprotein gp41, vFP16.02 Heavy Chain, vFP16.02 Light Chain |
6CDE | 6CDE | Cryo-EM structure at 3.8 A resolution of vaccine-elicited antibody vFP20.01 in complex with HIV-1 Env BG505 DS-SOSIP, and antibodies VRC03 and PGT122 | PGT122 Heavy chain, PGT122 Light Chain, VRC03 Light Chain, VRC03 Heavy Chain, Glycoprotein 41, Glycoprotein 120, vFP20.01 Heavy Chain, vFP20.01 Heavy chain |
6CCB | 6CCB | Crystal structure of 253-11 SOSIP trimer in complex with 10-1074 Fab | |
6CBP | 6CBP | Crystal structure of the single chain variable fragment of the DH270.6 bnAb in complex with the Man9-V3 glycopeptide | |
6CBJ | 6CBJ | Crystal Structure of DH270.3 Fab in complex with Man9 | |
6CBJ | 6CBJ | Crystal Structure of DH270.3 Fab in complex with Man9 | |
6C9W | 6C9W | Crystal Structure of a ligand bound LacY/Nanobody Complex | |
6C6Z | 6C6Z | Crystal structure of potent neutralizing antibody CDC2-C2 in complex with MERS-CoV S1 RBD | |
6C5V | 6C5V | An anti-gH/gL antibody that neutralizes dual-tropic infection defines a site of vulnerability on Epstein-Barr virus | |
6C5K | 6C5K | S25-23 Fab in complex with Chlamydiaceae LPS (Crystal form 2) | |
6C5K | 6C5K | S25-23 Fab in complex with Chlamydiaceae LPS (Crystal form 2) | |
6C5J | 6C5J | S25-23 Fab in complex with Chlamydiaceae LPS (Crystal form 1) | |
6C5J | 6C5J | S25-23 Fab in complex with Chlamydiaceae LPS (Crystal form 1) | |
6C5I | 6C5I | Unliganded S25-5 Fab | |
6C5I | 6C5I | Unliganded S25-5 Fab | |
6C5H | 6C5H | S25-5 Fab in complex with Chlamydiaceae-specific LPS antigen | |
6C5H | 6C5H | S25-5 Fab in complex with Chlamydiaceae-specific LPS antigen | |
6C09 | 6C09 | Ternary crystal structure of the 3C8 TCR-CD1c-monoacylglycerol complex | |
6BZD | 6BZD | Structure of 14-3-3 gamma R57E mutant bound to GlcNAcylated peptide | |
6BYL | 6BYL | Structure of 14-3-3 gamma bound to O-GlcNAcylated thr peptide | |
6BYK | 6BYK | Structure of 14-3-3 beta/alpha bound to O-ClcNAc peptide | |
6BYJ | 6BYJ | Structure of human 14-3-3 gamma bound to O-GlcNAc peptide | |
6BXC | 6BXC | Crystal structure of N-terminal fragment of Zebrafish Toll-Like Receptor 5 (TLR5) with Lamprey Variable Lymphocyte Receptor 9 (VLR9) bound | |
6BXA | 6BXA | Crystal structure of N-terminal fragment of Zebrafish Toll-Like Receptor 5 (TLR5) with Lamprey Variable Lymphocyte Receptor 2 (VLR2) bound | |
6BX4 | 6BX4 | The crystal structure of fluoride channel Fluc Ec2 with Monobody S9 | |
6BWI | 6BWI | 3.7 angstrom cryoEM structure of full length human TRPM4 | |
6BRB | 6BRB | Novel non-antibody protein scaffold targeting CD40L | |
6BP2 | 6BP2 | Therapeutic human monoclonal antibody MR191 bound to a marburgvirus glycoprotein | |
6BNL | 6BNL | Crystal structure of TCR-MHC-like molecule | |
6BNK | 6BNK | Crystal structure of TCR-MHC-like molecule | |
6BMT | 6BMT | Crystal Structure of a Recombinant form of Human Myeloperoxidase Bound to an Inhibitor from Staphylococcus delphini | |
6BKD | 6BKD | Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3D | |
6BKD | 6BKD | Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3D | |
6BKC | 6BKC | Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3B | |
6BKC | 6BKC | Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3B | |
6BKB | 6BKB | Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3A | |
6BKB | 6BKB | Structure of Hepatitis C Virus Envelope Glycoprotein E2 core from genotype 6a bound to broadly neutralizing antibody AR3A | |
6BJ2 | 6BJ2 | TCR589 in complex with HIV(Pol448-456)/HLA-B35 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024